High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia

Leukemia

Volumn 20, Issue 3, 2006, Pages 498-504

  Sainz Perez, A ^a   Gary Gouy, H ^a   Portier, A ^a   Davi, F ^b   Merle Beral, H ^b   Galanaud, P ^a   Dalloul, Ali ^a  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Apoptosis; CD5; CLL; Interleukin 24; Mda 7; p38MAP kinase

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 24; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL 2; PROTEIN KINASE LYN; PROTEIN MDA 7; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 24; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

EID: 33644508374     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404073     Document Type: Article

References (36)

1. Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med 1995; 333: 1052-1057; Erratum in: N Engl J Med 1995; 333:1515.
2. Hamblin TJ, Oscier DG. Chronic lymphocytic leukaemia: The nature of the leukaemic cell. Blood Rev 1997; 11: 119-128.
3. Dameshek W. Chronic lymphocytic leukemia: An accumulative disease of immunologically incompetent lymphocytes. Blood 1967; 29 (Suppl): 566-584.
4. Fu SM, Chiorazzi N, Kunkel HG. Differentiation capacity and other properties of leukemic cells of chronic lymphocytic leukemia. Immunol Rev 1979; 48: 23-44.
5. Perri RT. Impaired expression of cell surface receptors for B cell growh factors by chronic lymphocytic leukemia B cells. Blood 1986; 67: 943-948.
6. Lankester AC, van Schijndel GM, van der Schoot CE, van Oers MH, van Noesel CJ, van Lier RA. Antigen Receptor nonresponsiveness in chronic lymphocytic leukemia cells. Blood 1995; 86: 1090-1097.
7. Zimmerman TS, Godwin HA, Perry S. Studies of leukocyte kinetics in chronic lymphocytic leukemia. Blood 1968; 31: 277-291.
8. Decker T, Schneller F, Hipp S, Miething C, Jahn T, Duyster J et al. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27. Leukemia 2002; 16: 327-334.
9. Stevenson FK, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 2004; 103: 4389-4395.
10. Sanhes L, Tang R, Delmer A, DeCaprio JA, Ajchenbaum-Cymbalista F. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of 27kip1 by caspases. Leukemia 2003; 17: 1104-1111.
11. Damle RN, Ghiotto F, Valetto A, Albesiano E, Fais F, Yan XJ et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 2002; 99: 4087-4093.
12. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848-1854.
13. Bell SE, Goodnow CC. A selective defect in IgM antigen receptor synthesis and transport causes loss of cell surface IgM expression on tolerant B lymphocytes. EMBO J 1994; 13: 816-826.
14. Hippen KL, Tze LE, Behrens TW. CD5 maintains tolerance in anergic B cells. J Exp Med 2000; 191: 883-890.
15. Gary-Gouy H, Harriague J, Bismuth G, Platzer C, Schmitt C, Dalloul AH. Human CD5 promotes B-cell survival through stimulation of autocrine IL10 production. Blood 2002; 100: 4537-4543.
16. Bikah G, Carey J, Ciallella JR, Tarakhovsky A, Bondada S. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 1996; 274: 1906-1909.
17. Gary-Gouy H, Harriague J, Dalloul A, Donnadieu E, Bismuth G. CD5-negative regulation of B Cell Receptor signaling pathways originates from tyrosine residue Y 429 outside an immunoreceptor tyrosine-based inhibitory motif. J Immunol 2002; 168: 232-239.
18. Bauch A, Campbell KS, Reth M. Interaction of the CD5 cytoplasmic domain with the Ca2+/calmodulin-dependent kinase II delta. Eur J Immunol 1998; 28: 2167-2177.
19. Raman C, Kuo A, Deshane J, Litchfield DW, Kimberly RP. Regulation of Casein Kinase 2 by direct interaction with cell surface receptor CD5. J Biol Chem 1998; 273: 19183-19189.
20. Finke J, Ternes P, Lange W, Mertelsmann R, Dolken G. Expression of interleukin 10 in B lymphocytes of different origin. Leukemia 1993; 11: 1852-1857.
21. Ramachandra S, Metcalf RA, Fredrickson T, Marti GE, Raveche E. Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL. J Clin Invest 1996; 98: 1788-1793.
22. Fayad L, Keating MJ, Reuben JM, O'Brien S, Lee BN, Lerner S et al. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood 2001; 97: 256-263.
23. Renauld JC. Clas II cytokine receptors and their ligands: Key antiviral and inflammatory modulators. Nat Rev Immunol 2003; 3: 667-676.
24. Caudell EG, Mumm JB, Poindexter N, Ekmekcioglu S, Mhashilkar AM, Yang XH et al. The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J Immunol 2002; 168: 6041-6046.
25. Sarkar D, Su Z-Z, Lebedeva I V, Suane M, Gopalkrishnan RV, Dent P et al. mda-7 (IL-24): Signaling and functional roles. Biotechniques 2002; 33: 530-539.
26. Wang M, Tan Z, Zhang R, Kotenko SV, Liang P. IL24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/ IL-20R2. J Biol Chem 2002; 277: 7341-7347.
27. Sarkar D, Su ZZ, Lebedeva IV, Sauane M, Gopalkrishnan RV, Valerie K et al. mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci USA 2002; 99: 10054-10059.
28. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994; 265: 808-811.
29. Mentz F, Merle-Beral H, Dalloul A. Theophylline-induced B-CLL apoptosis is partly dependent on cyclic AMP production but independent of CD38 expression and endogenous IL-10 production. Leukemia 1999; 13: 78-84.
30. Orsini E, Guarini A, Chiaretti S, Mauro FR, Foa R. The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response. Cancer Res 2003; 63: 4497-4506.
31. Mendelson KG, Contois LR, Tevosian SG, Davis RJ, Paulson KE. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc Natl Acad Sci USA 1996; 93: 12908-12913.
32. Ringshausen I, Dechow T, Schneller F, Weick K, Oelsner M, Peschel C et al. Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells. Leukemia 2004; 18: 1964-1970.
33. Kishi H, Nakagawa K, Matsumoto M, Suga M, Ando M, Taya Y et al. shock induces G1 arrest through p53 phosphorylation at ser33 by activating p38MAPK without phosphorylation at ser15 and ser20. J Biol Chem 2001; 276: 39115-39122.
34. Ge B, Gram H, Di Padova F, Huang B, New L, Ulevitch RJ et al. activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science 2002; 295: 1291-1294.
35. Ohkusu-Tsukada K, Tominaga N, Udono H, yui K. Regulation of the maintenance of peripheral T-cell anergy by TAB1-mediated p38 alpha activation. Mol Cell Biol 2004; 24: 6957-6966.
36. Pers JO, Berthou C, Porakishvili N, Burdjanadze M, Le Calvez G, Abgrall JF et al. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia. Leukemia 2002; 16: 44-52.